Amelioration of CR-EAE with lisofylline: Effects on mRNA levels of IL-12 and IFN-γ in the CNS

Journal of Neuroimmunology

Volumn 110, Issue 1-2, 2000, Pages 13-19

  Du, Caigan ^a   Cooper, John C ^a   Klaus, Stephen J ^b   Sriram, Subramaniam ^a  

^a Multiple Sclerosis Res Laboratory   (United States)

^b Cell Therapeutics Inc   (United States)

Author keywords

Experimental allergic encephalomyelitis; IFN ; IL 12; Lisofylline

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; LISOFYLLINE; MESSENGER RNA; PROTEIN P40;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMAL; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE; FEMALE; GENE EXPRESSION; GUINEA PIGS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-12; MICE; MICE, INBRED STRAINS; MULTIPLE SCLEROSIS; PENTOXIFYLLINE; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0034597155     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00348-9     Document Type: Article

References (44)

1. Abraham E., Bursten S.L., Shemkar R., Allbee J., Tuder R., Woodson P., Guidot D.M., Rice G.C., Singer J.W., Repine J.E. Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after haemorrhage in mice. J. Exp. Med. 181:1995;569-575.
2. Adams D.O., Hamilton T.A. Molecular transductional mechanisms by which IFN and other signals regulate macrophage development. Immunol. Rev. 97:1987;5-27.
3. Bright J.J., Du C., Coon M., Sriram S., Klaus S.J. Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline. J. Immunol. 161:1998;7015-7022.
4. Bright J.J., Musuro B.F., Du C., Sriram S. Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalitis. J. Neuroimmunol. 82:1998;22-30.
5. Bunda M.J. Interleukin-12. J. Leuk. Biol. 55:1994;280-288.
6. Collart M.A., Belin D., Vassalli J.D., Kossodo S.D., Vassalli P. Gamma-interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin-1 and urokinase genes, which are controlled by short-lived repressors. J. Exp. Med. 164:1986;2113-2118.
7. Cross A.H., Keeling R.M., Goorha S., San M., Rodi C., Wyatt P.S., Manning P.T., Tisko T. Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis. J. Neuroimmunol. 71:1996;145-153.
8. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophage. J. Immunol. 141:1988;2407-2412.
9. Duijvestijn A.M., Schreiber A.B., Butcher E.C. Interferon-gamma regulates an antigen specific for endothelial cells involved in lymphocyte traffic. Proc. Natl. Acad. Sci. USA. 83:1986;9114-9118.
10. Dureli L., Bongioanni M.R., Cavallo R., Ferrero B., Ferri R., Ferri M.F., Bradac G.B., Riva A., Vai S., Geuna M., Bergamini L., Bergamasco B. Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis. Neurology. 44:1994;406-413.
11. Ehrlich G.D., Greenberg S., Abbott M.A. Innis M.A., Gelfand D.H., Sninsky J.J., White T.J. PCR-Protocols. 1990;325-330 Academic, New York.
12. Ferber I.A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco D.C., Steinman C., Dalton D., Fathman C.G. Mice with a disrupted IFNγ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:1996;5-12.
13. Fritz R.B., Russell J.P., Zhao M.-L. Persistence of an encephalitogenic T cell clone in the spinal cord during chronic, relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 89:1998;1-9.
14. Fritz R.B., Wang X., Zhao M.-L. Alterations in the spinal cord T cell repertoire during relapsing experimental autoimmune encephalomyelitis. J. Immunol. 164:2000;6662-6668.
15. Gubler U., Chua A.O., Schoenhaut D.S., Dwyer C.M., McComas W., Motyka R., Nabavi N., Wolitzky A.G., Quinn P.M., Familletti P.C., Gately M.K. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA. 88:1991;4133-4140.
16. Heremans H., Dillen C., Dijkmans R., Grau G., Billiau A. The role of cytokines in various animal models of inflammation. Lymphokine Res. 8:1989;329-333.
17. Hooper D.C., Baasra O., Marini J.C., Zborek A., Ohnishi S.T., Kean R., Champion J.M., Sarker A.B., Bobroski L., Farber J.L., Akaike T., Maeda H. Koprowski, H., 1997. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitric: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. USA. 94:(1997):1997;2528-2533.
18. Horwitz M.S., Evans C.F., McGavern D.B., Rodriguez M., Oldstone M.B.A. Primary demyelination in transgenic mice expressing interferon-γ Natl. Med. 3:1997;1037-1045.
19. Johns L.D., Flanders K.C., Ranges G.E., Sriram S. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor β1. J. Immunol. 147:1991;1792-1796.
20. Kamijo R., Le J., Shapiro D., Havell E.A., Huang S., Aguet M., Bosland M., Vilcek J. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharides. J. Exp. Med. 178:1993;1435-1440.
21. Kobayashi M., Fitz L., Ryan M., Hewick R.M., Clark S.C., Chen S., Loudon R., Sherman F., Perussia B., Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:1989;827-846.
22. Kolb H., Kolb-Bachofen V. Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunol. Today. 19:1998;556-561.
23. Krakowski M., Owens T. IFNγ confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26:1996;1641-1646.
24. Krakowski M., Owens T. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis. Eur. J. Immunol. 27:1997;2840-2847.
25. Leonard J.P., Waldburger K.E., Goldman S.J. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:1995;381-386.
26. Ling P., Gately M.K., Gubler U., Stern A.S., Lin P., Hollfelder K., Su C., Pan Y.-C.E., Hakimi J. Human Il-12 p40 homodimer binds to the Il-12 receptor but does not mediate biologic activity. J. Immunol. 154:1995;116-127.
27. List A., Maziarz R., Stiff P., Jansen J., Liesfeld L., Schuster M., Andrews D.F., Karanes I., Wolf S., Litzow M. Lisofylline reduces infection rate and improves survival in pts undergoing allogeneic bone marrow transplantation: result of a randomized, placebo-controlled trial. Blood. 88:1996;459.
28. Male D., Pryce G., Hughes C., Lantos P. Lymphocyte migration into brain modelled in vitro: control by lymphocyte activation, cytokines, and antigen. Cell. Immunol. 127:1990;1-11.
29. Mattner F., Fischer S., Guckes S., Jin S., Kaulen H., Schmitt E., Rude E., Germann T. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterdimer. Eur. J. Immunol. 23:1993;2202-2208.
30. Melby P.C., Yang Y.-Z., Cheng J., Zhao W. Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani. Infect. Immun. 66:1998;18-27.
31. Noronha A., Toscas A., Jensen M.A. Interferon beta decreases T-cell activation and interferon gamma production in multiple sclerosis. J. Neuroimmunol. 46:1993;145-153.
32. Owens T., Sriram S. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol. Clin. 13:1995;51-72.
33. Panitch H.S., Bever C.T. Clinical trials of interferons in multiple sclerosis. J. Neuroimmunol. 46:1993;155-160.
34. Renno T., Taupin V., Bourbonnière L., Verge G., Tran E., De Simone R., Krakowski M., Rodriguez M., Peterson A., Owens T. Interferon-γ in progression to chronic demyelination and neurological deficit following acute EAE. Mol. Cell. Neurosci. 12:1998;376-389.
35. Ruddle N.H., Bergman C.M., McGrath K.M., Lingeheld E.G., Grunnet M.L., Padula S.J., Clark R.B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1990;1193-1200.
36. Sethna M.P., Lampson L.A. Immune modulation within the brain: recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-γ J. Neuroimmunol. 34:1991;121-132.
37. Simmons R.D., Willenborg D.O. Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. J. Neurol. Sci. 100:1990;37-42.
38. Singer J.W., List A., Federighi D., Michnick T., Bursten S. Serum hydroperoxy and hydroxyoctadecadienoic acids (HPODE and HODE) increase in response to total body irradiation and are suppressed by lisofylline (LSF) in allogeneic BMT patients. Blood. 88:1996;458.
39. Smith T., Hewson A.K., Kingsley C.I., Leonard J.P., Cuzner M.L. Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat. Am J. Pathol. 150:1997;1909-1917.
40. Sriram S., Roberts C.A. Treatment of established chronic relapsing experimental allergic encephalomyelitis with anti-L3T4 antibodies. J. Immunol. 136:1986;4464-4469.
41. Tanuma N., Shin T., Kogure K., Matsumoto Y. Differential role of THF-α and IFN-γ in the brain of rats with chronic relapsing autoimmune encephalomyelitis. J. Neuroimmunol. 96:1999;73-79.
42. Tran E.H., Prince E.H., Owens T. IFN-γ shapes immune invasion of the central nervous system via regulation of chemokines. J. Immunol. 164:2000;2759-2768.
43. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T helper cells type 1 and cytotoxic lymphocytes. Blood. 84:1994;4008-4027.
44. Wolf S.F., Temple P.A., Kobayashi M., Young D., Dicig M., Lowe L., Dzialo R., Fitz L., Ferenz C., Hewick R.M., Kelleher K., Herrmann S.H., Clark S.C., Azzoni L., Chan S.H., Trinchieri G., Perussia B. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146:1991;3074-3081.